Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0012739 (
disseminated intravascular coagulation
)
8,673
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Muscle protein degradation and intracellular protease activities were investigated in
disseminated intravascular coagulation
(
DIC
), which is frequently associated with severe catabolic states such as sepsis and multiple organ failure.
DIC
was introduced in rats by repeated intravenous thrombin injections. Saline was injected in control rats. In the 28 rats (14 with
DIC
and 14 controls), the bilateral soleus (SOL) muscles were incubated in an oxygenated medium without cycloheximide (CH) to determine the release of tyrosine (Tyr) into the incubated medium. From 24 rats (12 with
DIC
and 12 controls), the SOL and extensor digitorum longus (EDL) muscles were harvested to measure the activities of proteasome and of cathepsins L and B. The contralateral muscles were incubated in a medium with 0.5 mM CH to determine the release of Tyr and
3-methylhistidine
(3-MH). The release of Tyr without CH (net proteolysis) from SOL muscles with
DIC
was greater than in controls (218 +/- 83.3 vs. 145 +/- 47.7 pmol/mg/h. However, the release of Tyr and 3-MH with CH (total proteolysis) and the activities of proteasome and cathepsins in
DIC
were nearly the same as those in controls. In both
DIC
and control rats, the total release of Tyr and proteasome activity were greater in SOL than in EDL muscles. These results suggest that reutilization of Tyr, reflecting protein synthesis, is suppressed in
DIC
and that the red slow muscle is more active in nonfibrillar proteolysis than the white fast muscle.
...
PMID:Modulation of muscle protein metabolism in disseminated intravascular coagulation. 764 9